Details of the Drug Reposition

General Information of This Drug (ID: DM32YTJ)

Drug Name
APN-301   DM32YTJ
Synonyms EMD-273063; Ch14.18-IL-2; Hu14.18-IL-2

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Melanoma DIS1RRCY 2C30 Phase 2 [1]
Neuroblastoma DISVZBI4 2D11.2 Phase 2 [2]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT00590824) Pilot hu14.18-IL2 in Resectable Recurrent Stage III or Stage IV Melanoma. U.S. National Institutes of Health.
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)